Literature DB >> 1801889

Hemodynamic effects of the D- and L-isomers of sotalol on normal myocardium.

H M Hoffmeister1, M Beyer, L Seipel.   

Abstract

This study investigated the hemodynamic effects of the D-isomer of sotalol in open-chest rats and compared this to the action of the L-isomer and the racemic DL-sotalol. Hemodynamic and additional isovolumic maximum measurements were registered at the end and 5 minutes after an intravenous infusion period of 7 minutes. DL- (1 and 2 mg/kg) and L-sotalol (2 mg/kg) caused a significant reduction in the heart rate and in the indices of contractility during and after infusion. D-sotalol (2, 4, and 8 mg/kg), however, decreased the contractility only transiently after very high doses at high plasma concentrations. Thus, while the effects of the beta-blocking L-isomer were comparable to those of DL-sotalol, only a slight and transient hemodynamic action of comparable doses of D-sotalol was found. These findings may be of significance for the proposed use of the D-isomer as a class-III antiarrhythmic agent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801889     DOI: 10.1007/BF00143531

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  24 in total

1.  Comparative effects of sotalol and propranolol on contractility of papillary muscles and adenyl cyclase activity of myocardial extracts of cat.

Authors:  W W Parmley; B Rabinowitz; L Chuck; G Bonorris; J P Katz
Journal:  J Clin Pharmacol New Drugs       Date:  1972-04

2.  Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999).

Authors:  P Somani; D L Watson
Journal:  J Pharmacol Exp Ther       Date:  1968-12       Impact factor: 4.030

3.  The effect of changes in cardiac frequency on left and right ventricular dP/dt max at different contractile states of the myocardium.

Authors:  H D Schmidt; H Hoppe; K D Müller
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1979-11

4.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

5.  Negative inotropic effect of class-I-antiarrhythmic drugs: comparison of flecainide with disopyramide and quinidine.

Authors:  H M Hoffmeister; A Hepp; L Seipel
Journal:  Eur Heart J       Date:  1987-10       Impact factor: 29.983

6.  Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation.

Authors:  P M Tande; H Refsum
Journal:  Pharmacol Toxicol       Date:  1988-05

7.  A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

8.  Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.

Authors:  J J Lynch; L A Coskey; D G Montgomery; B R Lucchesi
Journal:  Am Heart J       Date:  1985-05       Impact factor: 4.749

9.  Effects of graded intensity of oxygen deficiency on function and energy metabolism in post-ischaemic myocardium.

Authors:  H M Hoffmeister; R Storf; L Seipel
Journal:  Cardiovasc Res       Date:  1988-12       Impact factor: 10.787

10.  [Comparison of the hemodynamics effects of D-sotalol and D,L-sotalol].

Authors:  H M Hoffmeister; L Seipel
Journal:  Klin Wochenschr       Date:  1988-05-16
View more
  2 in total

1.  Long-term antiarrhythmic efficacy and safety of d-sotalol in patients with ventricular tachycardia and a low ejection fraction.

Authors:  K T Koch; D R Düren; P A van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

Review 2.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.